Twenty-three health stories recognized with a Media Orthopaedic Reporting Excellence (MORE) Award for outstanding coverage of bone and joint health stories
ROSEMONT, Ill., June 14, 2018 /PRNewswire-USNewswire/ -- The American Academy of Orthopaedic Surgeons (AAOS) announced the recipients of the 2018 MORE Awards, presented annually to journalists who accurately report on bone and joint health topics, increasing public awareness of musculoskeletal health issues and treatments.
This year's 23 award recipients represent a diverse group of health and medical writers, producers and freelance reporters from print, broadcast and online media outlets, and cover an array of topics, from orthopaedic innovation to improved quality of life for people of all ages. Entries were judged by a panel of orthopaedic surgeons, and evaluated for overall quality and accuracy.
"It's important for us as orthopaedic surgeons to recognize journalists for the work they do to inform the public about life-changing musculoskeletal treatments used to improve patients' lives," said AAOS President David A. Halsey, MD. "Journalists are our partners in disseminating accurate information to patients. When patients have accurate information about their treatment options, they can make an informed decision about their current and future care."
Entries for the 2019 MORE Awards is now open. Journalists and members of the public may start nominating stories by emailing [email protected]. The deadline for entries is Tuesday, October 9, 2018. Entries must have been published between October 1, 2017 and October 1, 2018.
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community. Aspire Health experienced a data security incident that may have involved personal and...